Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA clears Hayes modular hip system:

This article was originally published in Clinica

Executive Summary

Hayes Medical has received US FDA 510(k) clearance to market its UniSyn modular hip system. The system incorporates a patented locking mechanism, which can connect three components into one femoral hip stem. The product allows surgeons to select from a wide range of distal stems, metaphyseal bodies and neck components to create an optimal implant for each patient, says the El Dorado Hills, California company, which is to target the system to the primary and revision markets.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel